Back to News
Market Impact: 0.2
Acutus Medical Consensus Price Target Lowered by 66.67% to $0.51
Source: Nasdaq
Analyst EstimatesAnalyst Insights
The average one-year analyst price target for Acutus Medical was revised down 66.67% to $0.51 per share from $1.53, the prior estimate dated October 31, 2023. The article provides no reason for the revision or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.35
More News
- Coinbase has been battered over the past month. Morgan Stanley says steer clear
- Reliance’s Record $19 Billion Surge Lifts Nifty, Keeps India Bulls in the Game
- Apple reports after the bell. Options traders expect a big move
- Mizuho lowers Lumentum stock price target on Marvell acquisition
- Why is Apple stock falling afterhours today?
- RA Capital Management sells $9.13M in Lenz Therapeutics shares